GlaxoSmithKline AG - Fluarix Tetra 15 mcg / 0.5 ml, Injektionssuspension | | 62961 | | 02 | | Fluarix Tetra 15 mcg / 0.5 ml | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 25.08.2015 | | |
| Composition | haemagglutininum influenzae A (H1N1) (Virus Stamm A/California/7/2009 (H1N1)-like: reassortant virus NIB-74xp derived from A/Christchurch/16/2010) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Switzerland/9715293/2013 (H3N2)-like: reassortant virus NIB-88) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Brisbane/60/2008 (Victoria lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alfa-tocopheroli hydrogenosuccinas, residui: ovalbuminum max. 0.05 µg, saccharum max. 2 mg, formaldehydum max. 5 µg, natrii desoxycholas max. 65 µg, gentamicini sulfas nihil, hydrocortisonum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | Packungsbestandteile | | Suspension injectable | | | | Principe actif | Concentr. |
---|
Haemagglutininum Influenzae a (H1N1) (Virus Stamm A/california/7/2009 (H1N1)-Like: Reassortant Virus Nib-74Xp Derived from A/christchurch/16/2010) | 15 µg | Haemagglutininum Influenzae a (H3N2) (Virus Stamm A/switzerland/9715293/2013 (H3N2)-Like: Reassortant Virus Nib-88) | 15 µg | Haemagglutininum Influenzae b (Virus Stamm B/phuket/3073/2013 (Yamagata Lineage)) | 15 µg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
Alfa-Tocopheroli Hydrogenosuccinas | | | Disodium Phosphate Dodecahydrate | | | Formaldehydum | 5 µg | | Gentamicini Sulfas Nihil | | | Haemagglutininum Influenzae b Virus Stamm B/brisbane/60/2008 (Victoria Lineage) | 15 µg | | Hydrocortisonum Nihil | | | Potassium Chlorure | | | Potassium Dihydrogenophosphate | | | Magnesium Chloride Hexahydrate | | | Sodium Chlorure | | | Natrii Desoxycholas | 65 µg | | Octoxinolum-10 | | | Ovalbuminum | 0.05 µg | residui | Polysorbatum 80 | | | Saccharum | 2 mg | |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
Aucune entrée n'a été trouvée. |
|
|